First MagnaPharm Technical Action Review Meeting

at University of Bristol

16th Mar 2018

The Research Executive Agency of the European Commission (represented by EC Project Officer, Adriana Godeanu Metz) visited the University of Bristol to conduct our first MagnaPharm Technical Action Review (deliverable D4.8).

The key objectives were to assess:

- the degree to which the work plan has been carried out and all due deliverables have been completed

- the continued relevance of our objectives and their potential for scientific or industrial breakthrough

- how well resources have been planned and used in relation to the achieved progress

- the management procedures and methods of the action

- the expected potential scientific, technological, economic, competitive and social impact and plans for using and disseminating our results

The day kicked off with a welcome and opening by Adriana Godeanu Metz, followed by a tour de table. 

Nicole Dixon (Project Officer) then delivered an overview of the project, including dissemination & exploitation, Open Access, management and communication. 

The table was then opened to the Work Package leaders to present our scientific and technological progress to date with respect to the DoA. These presentations can be found here. 

After the presentations, the group were taken over to the new MagnaPharm Laboratory in the School of Chemistry, to demonstrate our work with the EM7-HV electromagnets and equipment funded by the H2020 FET-OPEN grant.  This was followed by a closed discussion of the panel and their expert feedback.

The MagnaPharm consortium would like to thank the external independent experts for taking part in this review and their key recommendations for the MagnaPharm Project:

  

Professor Joop Ter Horst - Strathclyde Institute of Pharmacy and Biomedical Sciences

Professor Yaroslav Khimyak - University of East Anglia

 

Professor Richard Hill - University of Nottingham

Ms Man-Sze Li - Innovation Expert & Private Investor

Consortium members In attendance from each of the partner sites were:

University of Bristol:

Dr Simon Hall

Jason Potticary 

Nicole Dixon

University of Limerick:

Prof Ursel Bangert

Dr Andrew Stewart

Dr Jennifer Cookman

University College London:

Prof Sally Price FRS

Dr Rui Guo

Dr Louise Price

Radboud University:

Prof Dr Peter Christianen

Dr Sanne Granneman

© 2017 MagnaPharm. All Rights Reserved

  • Facebook Clean Grey
  • Twitter Clean Grey
  • LinkedIn Clean Grey

This project has received funding from the European Union's Horizon 2020 Research and Innovation programme under grant agreement number 736899.

Email: Nicole.dixon@bristol.ac.uk